Investor Type | Firm |
Type of Fund | VC |
Industries | Investment Management • Life Science |
Stages | Early, Seed |
Investing | United Kingdom |
Boundary Capital is a UK-based venture capital firm that specializes in early and seed-stage technology investments. Founded in 2009 and located in London, they focus on backing companies in sectors like telecommunications, electronics, green and clean tech, materials, chemistry, healthcare, and life sciences. They are recognized for their impact investment initiatives, primarily investing in high-growth private technology companies that have the potential to positively impact millions of lives. Boundary Capital prides itself on investing not just capital but also time and expertise to ensure the success of their investee companies. Moreover, the firm offers tax-efficient investments and operates an AI EIS Fund approved by the HMRC as a Knowledge Intensive Fund, providing various tax reliefs to eligible investors. Boundary Capital's investment team is composed of partners with Blue-chip commercial experience, as well as academic backgrounds in life sciences, AI, and engineering. Their approach is supported by a proprietary investment model used to screen, compare, and monitor investments. The firm's core investment areas reflect the professional experiences of their partners who are entrepreneurs and serial investors with a track record of successful exits. Boundary Capital underlines a commitment to a low-initial-fee structure, with no further fees charged to investors until a performance threshold, exceeding 100% of the original investment, is met. Through a hands-on approach, they lend their considerable expertise to investee companies and maintain an active involvement in developing their portfolio enterprises.